Pages that link to "Q36930841"
Jump to navigation
Jump to search
The following pages link to Synergy between PPARgamma ligands and platinum-based drugs in cancer (Q36930841):
Displaying 50 items.
- PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer (Q21328702) (← links)
- The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention (Q24601222) (← links)
- Adipocytes: impact on tumor growth and potential sites for therapeutic intervention (Q26830077) (← links)
- Ubiquitin-mediated NFκB degradation pathway (Q26998535) (← links)
- Chemotherapy and chemoprevention by thiazolidinediones (Q27011352) (← links)
- Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy (Q27015257) (← links)
- Structural and Biochemical Basis for the Binding Selectivity of Peroxisome Proliferator-activated Receptor to PGC-1 (Q27650576) (← links)
- PPARγ as a Novel Therapeutic Target in Lung Cancer (Q28068114) (← links)
- The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines (Q28238709) (← links)
- Molecular mechanisms of cancer development in obesity (Q28253823) (← links)
- Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC (Q28478252) (← links)
- Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines (Q28481323) (← links)
- Discovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergies (Q28546587) (← links)
- Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer (Q28744237) (← links)
- Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer (Q33387721) (← links)
- Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma (Q33580777) (← links)
- Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer (Q33631471) (← links)
- Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells (Q33637896) (← links)
- Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer (Q33710548) (← links)
- Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro (Q33744855) (← links)
- Retracted: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome (Q33769492) (← links)
- Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions (Q33874365) (← links)
- Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas (Q33896731) (← links)
- Targeting the eicosanoid pathway in non-small-cell lung cancer (Q33936807) (← links)
- Integrated genomics of ovarian xenograft tumor progression and chemotherapy response (Q33968921) (← links)
- PPARγ is an E3 ligase that induces the degradation of NFκB/p65. (Q34318405) (← links)
- Obesity and cancer--mechanisms underlying tumour progression and recurrence (Q34425077) (← links)
- Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer (Q34878637) (← links)
- Synergistic Interactions between Heregulin and Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonist in Breast Cancer Cells (Q35011149) (← links)
- Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells (Q35817322) (← links)
- Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression (Q36014897) (← links)
- The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination (Q36090448) (← links)
- Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer (Q36113804) (← links)
- Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells (Q36608691) (← links)
- Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer (Q36661722) (← links)
- PPARgamma and Apoptosis in Cancer (Q36742811) (← links)
- Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells (Q36836697) (← links)
- Clinical Use of PPARgamma Ligands in Cancer (Q37021288) (← links)
- Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand (Q37056369) (← links)
- Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity (Q37079820) (← links)
- Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials. (Q37149246) (← links)
- Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment (Q37182802) (← links)
- Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours (Q37188588) (← links)
- Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin. (Q37226800) (← links)
- PPARgamma activation induces autophagy in breast cancer cells (Q37366778) (← links)
- KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines. (Q37468620) (← links)
- PPAR Agonists for the Prevention and Treatment of Lung Cancer (Q37681630) (← links)
- Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. (Q37734011) (← links)
- Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy. (Q37847515) (← links)
- PPAR gamma, bioactive lipids, and cancer progression (Q37971590) (← links)